NEW YORK, Jan. 5, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVCR, ZLAB, KALA, ORTX, and CTMX.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • NVCR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=NVCR&prnumber=010520231
  • ZLAB: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=ZLAB&prnumber=010520231
  • KALA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=KALA&prnumber=010520231
  • ORTX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=ORTX&prnumber=010520231
  • CTMX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=CTMX&prnumber=010520231

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-novocure-zai-lab-kala-pharmaceuticals-orchard-therapeutics-or-cytomx-therapeutics-301714575.html

SOURCE InvestorsObserver